Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (DE:RHO5)
XETRA:RHO5
Roche Holding AG (RHO5) Stock Price & Analysis
51 Followers
RHO5 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€244.35 - €247.10
Previous Close€245.2
Volume2.84K
Average Volume (3M)2.84K
Market Cap
€188.40B
Enterprise Value€210.55B
Total Cash (Recent Filing)CHF7.51B
Total Debt (Recent Filing)CHF25.39B
Price to Earnings (P/E)16.6
BetaN/A
Next Earnings
Jul 25, 2024EPS Estimate
€9.53Last Dividend Ex-Date
Mar 14, 2024Dividend Yield4.47%
Share Statistics
EPS (TTM)14.78
Shares Outstanding702,562,700
10 Day Avg. Volume0
30 Day Avg. Volume2,836
Standard Deviation0.05
R-Squared0.04
Alpha0.00155
Financial Highlights & Ratios
Price to Book (P/B)93.14
Price to Sales (P/S)2.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€262.58Price Target Upside7.09% Upside
Rating ConsensusHold
Number of Analyst Covering11
Roche Holding AG News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceThe company confirmed FY24 guidance, aiming for mid-single digit sales growth and core EPS development in line with sales.
Financial Performance1Q24 group sales met consensus expectations, showing stability in the company's financial performance.
Sales GrowthExcluding the prior year's CV-19 headwind, group, pharma, and diagnostics sales showed strong growth rates.
Bears Say
Earnings ForecastAnalyst suggests that consensus forecasts for the fiscal year might not be upgraded due to current estimates.
Financial PerformanceMid-single-digit growth guidance for 2024 suggests downside to consensus sales and EPS.
Investor SentimentShares are considered cheap and unloved, indicating a lack of investor enthusiasm despite low valuation.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
19.34% Mutual Funds
9.09% Other Institutional Investors
71.58% Public Companies and
Individual Investors
RHO5 FAQ
What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest stock price was €244.35 and its highest was €247.10 in the past 12 months.
What is Roche Holding AG’s market cap?
Currently, no data Available
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s upcoming earnings report date is Jul 25, 2024 which is in 71 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Feb 01, 2024. The company reported €8.644 earnings per share for the quarter, beating the consensus estimate of €8.541 by €0.102.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Undervalued.
Does Roche Holding AG pay dividends?
Roche Holding AG pays a Annually dividend of €9.8 which represents an annual dividend yield of 4.47%. See more information on Roche Holding AG dividends here
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is €9.53.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 702,562,700 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of €8.644 in its last earnings report, beating expectations of €8.541. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in DE:RHO5
---
Roche Holding AG Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€262.58 (7.09% Upside)
€262.58 (7.09% Upside)
Blogger Sentiment
Bullish
DE:RHO5 Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.83%
12-Months-Change
Fundamentals
Return on Equity
39.18%
Trailing 12-Months
Asset Growth
12.82%
Trailing 12-Months
Company Description
Roche Holding AG
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
---
RHO5 Company Deck
---
RHO5 Earnings Call
Q4 2024
0:00 / 0:00
---
RHO5 Stock 12 Month Forecast
Average Price Target
€262.58
▲(7.09% Upside)
Technical Analysis
Best Analysts Covering RHO5
1 Year
1 Year Success Rate
33/36 ratings generated profit
1 Year Average Return
+13.65%
reiterated a sell rating 21 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +13.65% per trade.
---